<p>The Log-rank test showed that the survival times were significantly longer in patients with low serum YKL-40 than those of high serum YKL-40 (<i>p</i> = 0.041).</p
This study was to explore the association between the serum YKL-40 level and the clinical characteri...
<p>Survival rates were calculated by the Kaplan-Meier test and compared by log-rank test. (solid lin...
Kaplan Meier survival curve for NSCLC patients stratified by ALI systemic inflammation, ALI < 24 and...
<p>Log-rank test determined that the PFS in low serum YKL-40 group was significantly longer than tho...
<p><b>a</b> OS curve classified by YKL-40 in all patients (n = 212). <b>b</b> OS curve classified by...
<p>D shows the survival curves for 0–3 elevated biomarkers. The P-value refers to the log-rank test ...
<p>D shows the survival curves for 0–3 elevated biomarkers. The P-value refers to the log-rank test ...
<p> (a) OS curves of SACC patients according to USP22 immunostaining; (b) DFS curves of SACC patient...
<p>D shows the survival curves for no elevated biomarkers (yellow), only elevated IL-6 (blue), only ...
<p>The patients were stratified into two groups based on the median of the T cell proportion among t...
<p>For each variable, the patients were split in two groups, namely those with values above the medi...
This study was to explore the association between the serum YKL-40 level and the clinical characteri...
<p><i>P</i> values were determined by the log-rank test. (A) Distant recurrence-free survival, (B) d...
<p>Disease-free survival (A) and Overall survival (B) for low NPAA and high NPAA patients. P values ...
<p>Survival curves were analyzed by Kaplan-Meier method and log-rank test. Patients with high POTEE ...
This study was to explore the association between the serum YKL-40 level and the clinical characteri...
<p>Survival rates were calculated by the Kaplan-Meier test and compared by log-rank test. (solid lin...
Kaplan Meier survival curve for NSCLC patients stratified by ALI systemic inflammation, ALI < 24 and...
<p>Log-rank test determined that the PFS in low serum YKL-40 group was significantly longer than tho...
<p><b>a</b> OS curve classified by YKL-40 in all patients (n = 212). <b>b</b> OS curve classified by...
<p>D shows the survival curves for 0–3 elevated biomarkers. The P-value refers to the log-rank test ...
<p>D shows the survival curves for 0–3 elevated biomarkers. The P-value refers to the log-rank test ...
<p> (a) OS curves of SACC patients according to USP22 immunostaining; (b) DFS curves of SACC patient...
<p>D shows the survival curves for no elevated biomarkers (yellow), only elevated IL-6 (blue), only ...
<p>The patients were stratified into two groups based on the median of the T cell proportion among t...
<p>For each variable, the patients were split in two groups, namely those with values above the medi...
This study was to explore the association between the serum YKL-40 level and the clinical characteri...
<p><i>P</i> values were determined by the log-rank test. (A) Distant recurrence-free survival, (B) d...
<p>Disease-free survival (A) and Overall survival (B) for low NPAA and high NPAA patients. P values ...
<p>Survival curves were analyzed by Kaplan-Meier method and log-rank test. Patients with high POTEE ...
This study was to explore the association between the serum YKL-40 level and the clinical characteri...
<p>Survival rates were calculated by the Kaplan-Meier test and compared by log-rank test. (solid lin...
Kaplan Meier survival curve for NSCLC patients stratified by ALI systemic inflammation, ALI < 24 and...
DOI
Add to ORKG